# Opmed.ai

> Opmed.ai sells AI and network-science software to hospitals and health systems for predicting procedure durations, allocating operating-room blocks, scheduling staff, and coordinating patient flow. Its current platform covers surgical, procedural, and rehabilitation services; named deployments and collaborations include Geisinger, Mayo Clinic, and AtlantiCare.

- **Founded:** 2022
- **Headquarters:** Boston, United States
- **Founders:** Dr. Mor Brokman Meltzer (Co-Founder & CEO), Avi Paz (Co-Founder & CTO), Prof. Baruch Barzel (Co-Founder & Chief Scientist)
- **Products:** Surgical Services, Procedural Services, Rehabilitation, Forecast, Allocate, Adjust, Custom AI Workflow
- **Notable:** Raised a publicly confirmed USD 15 million Series A in May 2024., Geisinger publicly announced implementation and initial results in October 2024., Earlier company-published Mayo case study reports mean absolute case-duration error declining from 60 to 34 minutes.

## Products & services

- **Surgical Services** — Case-duration prediction, live schedule optimization, surgical block allocation, staffing, throughput insights, and EHR-connected workflows.
- **Procedural Services** — Duration prediction and coordination of rooms, staff, equipment, and recovery flow for procedural settings, including non-operating-room anesthesia.
- **Rehabilitation** — Therapist and patient scheduling, resource allocation, treatment-minute planning, and adjustments for cancellations and staffing changes.
- **Forecast, Allocate, Adjust** — Platform capabilities for predicting operational demand, matching resources to needs, and responding to disruptions throughout the day.
- **Custom AI Workflow** — Workflow mapping, local rule configuration, exception handling, and recommendation logic tailored to a healthcare organization.

## Achievements

- Raised a publicly confirmed USD 15 million Series A in May 2024.
- Geisinger publicly announced implementation and initial results in October 2024.
- Earlier company-published Mayo case study reports mean absolute case-duration error declining from 60 to 34 minutes.
- June 2026 reporting of the ACC.26 Mayo collaboration describes 643 validation procedures and mean absolute error declining from 1.13 to 0.564 hours.
- Selected by AtlantiCare for a rollout across more than 50 OR and procedural spaces in January 2026.

## Latest updates

- **2026-01** — AtlantiCare selection reported for more than 50 operating rooms and procedural spaces, with Oracle Cerner integration.
- **2026-06** — ACC.26 cardiovascular prediction findings reported: 643 validation cases and roughly 50% lower mean absolute error for the best-performing model.
- **2026-06** — Grove Ventures published a founder interview on focus, prior startup failure, healthcare sales, and moving the CEO to Boston.

## Links

- Website: https://www.opmed.ai/
- LinkedIn: https://www.linkedin.com/company/opmedai/

---

Profile page: https://yespress.io/opmed-ai
Published by YesPress — https://yespress.io
Last updated: 2026-10-04